An exploratory comparative case series of calcitonin gene-related peptide monoclonal antibodies in patients with migraine with rosacea

Br J Dermatol. 2023 Nov 16;189(6):776-778. doi: 10.1093/bjd/ljad277.

Authors

Twan Sia¹, Taylor Webb¹, Shufeng Li^{1

2}, Leon S Moskatel³, Anne Lynn S Chang¹

Affiliations

¹ Department of Dermatology, Stanford University School of Medicine, Redwood City.
² Department of Urology, Stanford University School of Medicine, Center for Academic Medicine, Palo Alto.
³ Department of Neurology and Neurological Sciences, Stanford Health Care, Stanford, CA, USA.

PMID: 37596936
DOI: 10.1093/bjd/ljad277

No abstract available

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized
Calcitonin Gene-Related Peptide
Humans
Migraine Disorders* / drug therapy
Rosacea*

Substances

Calcitonin Gene-Related Peptide
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized